Hemab (private company)
See something wrong or missing? Let us know
Offices:Copenhagen
Industry:BiotechHealth services
Business model:B2B
Hemab Therapeutics is a biotech company developing next generation therapeutics for serious underserved bleeding and thrombosis disorders
Investors:
we tracked 11 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 347M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Belgium
Netherlands
Austria
Germany
Switzerland
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain
United Kingdom